Home Capital Company in the news

Sequoia, GIC invest in TPG’s Novotech at US$2.3 bil valuation

Bloomberg
Bloomberg2/2/2021 09:34 AM GMT+08  • 2 min read
Sequoia, GIC invest in TPG’s Novotech at US$2.3 bil valuation
The Sydney-based firm has increased revenues by more than 30% a year under TPG’s ownership since 2017.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Sequoia Capital and Singapore sovereign fund GIC Pte are among investors that agreed to buy a stake in clinical research and testing provider Novotech Pty from TPG, people with knowledge of the matter said.

Kaiser Foundation Hospitals also plans to invest in Novotech, according to the people, who asked not to be identified because the information is private. TPG is selling more than 10% of Novotech in a transaction valuing the company at over US$2.3 billion, said Joel Thickins, head of Australia and New Zealand for TPG Capital Asia.

The clinical research firm is preparing for an initial public offering in Hong Kong later this year, said Thickins, who is also chairman of Novotech. The valuation makes the company one of the most successful investments for the private equity group in Asia, he said.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.
Unlock unlimited access to premium articles with less than $9 per month. Subscribe Now